News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
898,597 Results
Type
Article (89706)
Company Profile (667)
Press Release (808199)
Multimedia
Podcasts (285)
Webinars (44)
Section
Business (267531)
Career Advice (4177)
Deals (40169)
Drug Delivery (247)
Drug Development (92167)
Employer Resources (212)
FDA (18747)
Job Trends (17566)
News (399666)
Policy (40038)
Tag
2025 Best Places to Work (26)
2026 Best Places to Work (40)
2027 BioCapital Standard (5)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Standard (6)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 NextGen (5)
2027 Pharm Country Digital (4)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (3113)
Academic (2)
Accelerated approval (77)
ADA (54)
Adcomms (44)
Allergies (238)
Alliances (57001)
ALS (293)
Alzheimer's disease (2170)
Antibody-drug conjugate (ADC) (786)
Approvals (19351)
Artificial intelligence (1153)
ASCO (350)
Autoimmune disease (542)
Automation (86)
Bankruptcy (414)
Belgium (47)
Best Places to Work (12636)
BIO (84)
Biologics (124)
Biomarkers (1)
BIOSECURE Act (23)
Biosimilars (309)
BioSpace Insights (272)
Biotechnology (340)
Bispecific (65)
Bladder cancer (253)
Brain cancer (105)
Breast cancer (987)
Cancer (8125)
Cardiovascular disease (689)
Career advice (3640)
Career pathing (65)
CAR-T (466)
CDC (82)
CDMO (241)
Celiac Disease (9)
Cell-line development (2)
Cell therapy (1286)
Cervical cancer (69)
Clinical research (81313)
Collaboration (2912)
Commercialization (77)
Company closure (10)
Compensation (1952)
Complete response letters (129)
COVID-19 (3089)
CRISPR (155)
CRO (10)
C-suite (1722)
Cystic fibrosis (183)
Data (11254)
Decentralized trials (4)
Denatured (113)
Depression (230)
Dermatology (210)
Diabetes (856)
Diagnostics (7959)
Digital health (88)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (570)
Drug pricing (255)
Drug shortages (41)
Duchenne muscular dystrophy (389)
Earnings (104836)
Editorial (85)
Employer branding (27)
Employer resources (184)
ESMO (441)
Events (142090)
Executive appointments (1387)
Eye disease (28)
FDA (23908)
Fibrodysplasia Ossificans Progressiva (17)
Fragile X (6)
Friedreich's ataxia (29)
Frontotemporal dementia (43)
Funding (2400)
Gene editing (323)
Generative AI (116)
Gene therapy (997)
GLP-1 (1420)
Government (5638)
Grass and pollen (8)
Guidances (446)
Healthcare (21536)
Hematology (241)
HIV (128)
Huntington's disease (94)
Idiopathic pulmonary fibrosis (16)
IgA nephropathy (155)
Immunology and inflammation (434)
Immuno-oncology (168)
Indications (303)
Infectious disease (3551)
Inflammatory bowel disease (286)
Inflation Reduction Act (17)
Influenza (168)
Intellectual property (393)
Interviews (830)
IPO (18072)
IRA (61)
Job creations (5211)
Job search strategy (2883)
JPM (73)
Kidney cancer (32)
Kidney disease (184)
Labor market (154)
Layoffs (734)
Leadership (70)
Legal (10180)
Licensing (142)
Liver cancer (121)
Longevity (58)
Lung cancer (1119)
Lung diease (29)
Lymphoma (572)
Machine learning (78)
Management (72)
Manufacturing (1674)
Marketing (43)
MASH (261)
Medical affairs (6)
Medical device (15491)
Medtech (15832)
Melanoma (255)
Mergers & acquisitions (23661)
Metabolic disorders (2183)
Middle East (2)
mRNA (348)
Multiple sclerosis (264)
Multispecific (7)
NASH (24)
Netherlands (44)
Neurodegenerative disease (643)
Neuropsychiatric disorders (155)
Neuroscience (4399)
Neurotech (4)
NextGen: Class of 2026 (7718)
Non-profit (5176)
Now hiring (103)
Obesity (1032)
Opinion (411)
Ovarian cancer (303)
Pain (357)
Pancreatic cancer (467)
Parkinson's disease (497)
Partnered (54)
Patents (822)
Patient advocacy (9)
Patient recruitment (989)
Patient selection (125)
Peanut (81)
People (69199)
Peptides (47)
Pharmaceutical (83)
Pharmacy benefit managers (43)
Phase 1 (25082)
Phase 2 (35325)
Phase 3 (26624)
Pipeline (14831)
Policy (435)
Postmarket research (3561)
Preclinical (11221)
Press Release (74)
Prostate cancer (415)
Psychedelics (105)
Radioligand (3)
Radiopharmaceuticals (452)
Rare diseases (1625)
Real estate (7479)
Recruiting (84)
Regenerative medicine (40)
Regulatory (31954)
Reports (104)
Research institute (2824)
Resumes & cover letters (657)
Rett syndrome (60)
RNA editing (39)
RSV (107)
Saudi Arabia (1)
Schizophrenia (231)
Series A (411)
Series B (287)
Series C (1)
Service/supplier (17)
Sickle cell disease (153)
Special edition (38)
Spinal muscular atrophy (201)
Sponsored (61)
Startups (4409)
State (2)
Stem cells (8)
Stomach cancer (25)
Substance use disorders (23)
Supply chain (175)
Switzerland (26)
Tariffs (109)
Tax incentives (2)
The Weekly (169)
Vaccines (1459)
Venture capital (188)
Weight loss (686)
Wet AMD (8)
Women's health (191)
Women in leadership (2)
Worklife (28)
Date
Today (25)
Last 7 days (764)
Last 30 days (3915)
Last 365 days (33876)
2026 (31227)
2025 (33214)
2024 (37866)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57662)
2019 (51333)
2018 (39119)
2017 (37186)
2016 (38329)
2015 (44431)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1311)
Alabama (118)
Alaska (7)
Arizona (495)
Arkansas (17)
Asia (53234)
Australia (9379)
California (17452)
Canada (4805)
China (2079)
Colorado (776)
Connecticut (780)
Delaware (550)
Europe (122922)
Florida (2647)
Georgia (567)
Hawaii (5)
Idaho (70)
Illinois (1507)
India (158)
Indiana (788)
Iowa (37)
Japan (791)
Kansas (161)
Kentucky (69)
Louisiana (73)
Maine (99)
Maryland (2058)
Massachusetts (12630)
Michigan (477)
Minnesota (959)
Mississippi (8)
Missouri (192)
Montana (38)
Nebraska (31)
Nevada (209)
New Hampshire (94)
New Jersey (4627)
New Mexico (38)
New York (4548)
North Carolina (2258)
North Dakota (14)
Northern California (8915)
Ohio (545)
Oklahoma (32)
Oregon (55)
Pennsylvania (3346)
Puerto Rico (38)
Rhode Island (66)
South America (1674)
South Carolina (105)
South Dakota (2)
Southern California (6961)
Tennessee (293)
Texas (2903)
United States (61869)
Utah (531)
Vermont (2)
Virginia (437)
Washington D.C. (90)
Washington State (1391)
West Virginia (4)
Wisconsin (200)
Wyoming (6)
898,597 Results for "molmed s p a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
EVIDENT Completes Acquisition of CrestOptics S.p.A.
October 5, 2026
·
4 min read
Press Releases
/U P D A T E - Interlude Biopharma Co./
November 19, 2026
·
7 min read
Mergers & acquisitions
Lilly’s early-stage M&A quest finds $1.5B deal for Calytrix’s blood cancer work
Eli Lilly’s business development team has inked 14 buyouts this year so far, with Calytrix Bio tucking into the pharma’s oncology pipeline.
November 16, 2026
·
1 min read
·
Annalee Armstrong
China
China’s licensing deals soar as US biotechs enjoy a bumper M&A year
China may be taking the majority of licensing deals this year but those transactions don’t tell the whole story, according to Locust Walk, which points to the spike in M&A among U.S. biotechs as leveling the playing field.
October 21, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
AINN-P1: Small Model, Big Intelligence
AINN-P1: Small Model, Big IntelligenceHow does a 167M-parameter protein foundation model outperform a 650M general-purpose model on the tasks that matter?
September 10, 2026
·
1 min read
Press Releases
AB Science will hold a web conference on Wednesday, October 14, 2026, from 6:00 p.m. to 7:30 p.m.
October 12, 2026
·
3 min read
Business
Genmab and AbbVie’s Epkinly win, a rush of deals, Sarepta’s turnaround hopes, more
New data for Genmab and AbbVie’s bispecific antibody Epkinly wowed analysts and could set the partners up for an expanded approval in diffuse large B cell lymphoma; deals have flowed steadily this week, including Novartis’ nearly $8 billion bet on mRNA drugs with China’s Abogen Biosciences; and could Sarepta Therapeutics turn things around from last year’s annus horribilis?
October 7, 2026
·
2 min read
·
Jef Akst
China
Without US action on China’s innovation blitz, biotech leaders see a Rust Belt future
Policy uncertainty is hampering the growth of U.S. biotech as China rises thanks to carefully planned investment in the industry, experts said during a
BioSpace
webinar.
November 11, 2026
·
5 min read
·
Annalee Armstrong
Drug Development
Sanofi’s axing of Nurix STAT6 program ‘not a target-related issue’
Sanofi has discontinued an early-stage STAT6 degrader program licensed from Nurix Therapeutics, a decision analysts say is related to the asset itself or Sanofi’s strategic reprioritization rather than the drug class more broadly.
November 4, 2026
·
3 min read
·
Heather McKenzie
Press Releases
Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference
May 18, 2026
·
1 min read
1 of 89,860
Next